To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
NovaQuest closes pharmaceutical fund on $459m
A 2010 spin-out out of pharmaceutical services company Quintiles, NovaQuest had targeted $500m for its Fund III.
